Healthcare

Washington, D.C. – U.S. Representative Lloyd Doggett (D-Austin) and Senators Elizabeth Warren (D-Mass.) and Angus King (I-Maine) sent a letter to Department of Commerce (DOC) Secretary Gina Raimondo and Department of Health and Human Services (HHS) Secretary Xavier Becerra asking for information on the membership, process, timeline, and scope of work of the recently announced Interagency Working Group for Bayh-Dole.

Washington, D.C. – U.S. Representatives Lloyd Doggett (D-Texas) and Katie Porter (D-Calif.) and U.S. Senators Elizabeth Warren (D-Mass.), Chuck Grassley (R-Iowa), and Bob Casey (D-Pa.) sent a bipartisan letter to Secretary of Health and Human Services (HHS) Xavier Becerra and Centers for Medicare and Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure, calling on CMS to strengthen its proposed rule on nursing home ownership transparency to benefit patients. The lawmakers are urging CMS to incorporate the provisions they recommend and implement this long overdue rule. 

Washington, D.C. – Today, U.S. Representatives Lloyd Doggett (D-TX), ranking member of the House Ways and Means Health Subcommittee, and Nanette Diaz Barragán (D-CA), member of the House Energy & Commerce Health Subcommittee, led a group of 113 Members in urging the Centers for Medicare and Medicaid Services (CMS) to use its existing executive authority to further improve coverage of medically necessary dental care.

Washington, D.C. – U.S. Representative Lloyd Doggett (D-Austin), Ranking Member of the Ways and Means Health Subcommittee, introduced the Medicare Fraud Detection and Deterrence Act—legislation that would equip the Centers for Medicare & Medicaid Services (CMS) with the additional authority it needs to hold convicted Medicare fraudsters accountable and to stop repeat offenders. He also introduced the Preventing Medicare Telefraud Act—companion legislation to establish reasonable guardrails to prevent tens of billions of dollars in telehealth-related fraud concerning high-cost durable medical equipment and lab testing.

Washington, D.C. – Today, U.S. Representative Lloyd Doggett (D-TX), Ranking Member of the Ways and Means Health Subcommittee, responded to the Department of Health and Human Services’ decision to deny a petition for a hearing concerning price gouging on prostate cancer drug Xtandi, which was developed with taxpayer dollars.